Dialysis Dialysis Zhongwen Zhongwen Dialysis Zhongwen dasarenamistiko Minggu, 24 Juni 2018 Nivolumab versus everolimus in advanced renalcell. Backgroundnivolumab, a programmed demise 1 (pd1) checkpoint inhibitor, was related to enc...
